DHFR expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.778800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.713200E-01
Normal-vs-Stage2
8.328800E-01
Normal-vs-Stage3
6.059200E-01
Normal-vs-Stage4
8.933200E-01
Stage1-vs-Stage2
4.229000E-01
Stage1-vs-Stage3
3.440200E-01
Stage1-vs-Stage4
7.014000E-01
Stage2-vs-Stage3
3.096600E-01
Stage2-vs-Stage4
9.838600E-01
Stage3-vs-Stage4
4.122000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.693400E-01
Normal-vs-AfricanAmerican
7.409000E-01
Normal-vs-Asian
7.796000E-01
Caucasian-vs-AfricanAmerican
4.392000E-01
Caucasian-vs-Asian
7.506200E-01
AfricanAmerican-vs-Asian
3.963200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.993600E-01
Normal-vs-Female
7.467200E-01
Male-vs-Female
1.976620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.654600E-01
Normal-vs-Age(41-60Yrs)
7.034600E-01
Normal-vs-Age(61-80Yrs)
9.819000E-01
Normal-vs-Age(81-100Yrs)
7.231000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.016640E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.787580E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.873650E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.821850E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.581000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.633400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.623400E-01
Normal-vs-Daily Drinker
9.922400E-01
Normal-vs-Weekly Drinker
8.544200E-01
Normal-vs-Occasional Drinker
9.815000E-01
Normal-vs-Social Drinker
8.110600E-01
Non Drinker-vs-Daily Drinker
6.883000E-01
Non Drinker-vs-Weekly Drinker
5.133600E-01
Non Drinker-vs-Occasional Drinker
6.653600E-01
Non Drinker-vs-Social Drinker
9.720600E-01
Daily Drinker-vs-Weekly Drinker
7.721600E-01
Daily Drinker-vs-Occasional Drinker
9.862200E-01
Daily Drinker-vs-Social Drinker
6.762000E-01
Weekly Drinker-vs-Occasional Drinker
7.440000E-01
Weekly Drinker-vs-Social Drinker
4.504000E-01
Occasional Drinker-vs-Social Drinker
6.050600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.911600E-01
Normal-vs-Grade 2
9.377600E-01
Normal-vs-Grade 3
8.946400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.901690E-02
Grade 1-vs-Grade 3
7.112000E-02
Grade 1-vs-Grade 4
7.911600E-01
Grade 2-vs-Grade 3
3.713200E-01
Grade 2-vs-Grade 4
9.377600E-01
Grade 3-vs-Grade 4
8.946400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.521400E-01
Normal-vs-NonDiabetic
8.469600E-01
Diabetic-vs-NonDiabetic
2.440500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.218000E-01
Normal-vs-NoPancreatitis
9.648200E-01
Pancreatitis-vs-NoPancreatitis
3.616800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.111800E-01
Normal-vs-N1
8.597200E-01
N0-vs-N1
7.409600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.564200E-01
Normal-vs-TP53-NonMutant
6.837000E-01
TP53-Mutant-vs-TP53-NonMutant
1.449590E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
